Virginia Society of Health-System Pharmacists

Latest News and News Archives

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 04/08/2027 10:57 AM | Steve Glass (Administrator)

    Call for Presentation Proposals and Posters for the Spring Seminar, April 8-10, Kalahari Resort, Spotsylvania

    VSHP is accepting speaker proposals that will provide quality continuing education to our members. Please see deadlines below.

    Thank you for supporting the educational mission of VSHP!

    The 2027 Spring Hot Topics list is located below. The VSHP Education Committee will consider all topics for presentation, with additional consideration for all presentations related to subjects on the Hot Topics list.   Presentations with interactive activities are encouraged.  Pharmacists, residents and technicians are encouraged to submit.

    Here is the link for the Presentation/Pearl proposals -- https://docs.google.com/forms/d/e/1FAIpQLSfOrw-yQSJa7wzjA97pM_n_1MXb_EDH9TzEcfSlRQBrSEWiQw/viewform?usp=publish-editor

    • Submit by Thursday 12/17/2026

     

    Here is the link for the Poster proposals -- https://docs.google.com/forms/d/e/1FAIpQLScIbf2s5jPbvFxJDYV34X0fm9bcql4JdV_v9PBTccef1vju8A/viewform?usp=publish-editor

    • Submit by Monday 2/15/27

     

    Hot topics

    • Medication safety and diversion: medication safety events, diversion investigations, controlled substances, and narcotic waste.
    • Reimbursement and financial pressures: billing and reimbursement, 340B, cost containment, and reducing drug spend.
    • Law and regulation: Board of Pharmacy topics, law updates, and changing regulations.
    • AI and pharmacy: how AI may affect pharmacy practice and how it is being used in hospital systems and EHRs.
    • EHRs and pharmacy informatics: Epic, EHR optimization, overrides, and informatics.
    • Ambulatory care: ambulatory practice and provider office topics.
    • Guidelines and new therapies: guideline updates, new and pipeline drugs, and antibiotics.
    • Workforce and role development: technician growth and retention, and expanding technician and pharmacist roles.

    Hot topics with an administrative or leadership focus

    • People management and workforce support: HR offerings, personnel management, technician retention, remote teams, and burnout.
    • Leadership development: leadership growth, leadership pearls, and clinical leadership.
    • Financial management: financial review, finance topics, cost savings, cost containment, and drug-spend strategies.
    • Reimbursement and policy impacts: billing changes, outpatient reimbursement, 340B changes, and the broader healthcare landscape.
    • Project management: practical project management topics.
    • Regulatory and operational change: law and Board of Pharmacy updates, remote dispensing rules, and pharmacy technology implementation.
    • Technology and workflow improvement: EHR optimization, AI integration, and pharmacy software.

     

     


  • 11/17/2026 3:08 PM | Steve Glass (Administrator)

    VSHP and the Virginia Pharmacy Association (VPhA) are working together to plan the 2027 Pharmacy Legislative Day, bringing pharmacy professionals together to advocate for our profession and the patients we serve.

    Join your pharmacy colleagues in Richmond on January 20 to help strengthen pharmacy’s voice in Virginia. Registration for VSHP and VPhA members is $25.

    Event Details

    Date: Wednesday, January 20, 2027
    Time: 7:00 a.m.–3:00 p.m.
    Staging Location: VCU Biotech Center
                    800 E Leigh Street
                    Richmond, VA 23298

    Registration is open November 16, 2026–January 8, 2027, or until capacity is reached.

    How to Register

    1. Visit the 2027 Pharmacy Legislative Day webpage and click “REGISTER HERE.”
    2. Select “Non-Member of VPhA” to link your registration to the VSHP group.
    3. Enter coupon code VSHP27 when prompted at the end of the registration form to receive the $25 member rate.
    4. Complete the form and submit payment.

    For registration assistance, please contact the VPhA Office at jyork@virginiapharmacists.org.

    We look forward to a strong VSHP presence as we come together to advance pharmacy in Virginia!

    Josh Crawford & Nik Lawson

    VSHP Legislative Chairs


  • 11/12/2026 12:00 PM | Steve Glass (Administrator)

    VSHP Webinar 

    November 12, 2026 – 12:00pm-1:00 pm

    Wake-Up Call: Amantadine vs Modafinil in the Neurocritical Care Patient

    Speaker:

    Savannah Kangas, Pharm.D.

    PGY1 Resident Pharmacist

    Chippenham & Johnston-Willis Hospitals

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • ·         Describe the common neuro deficit conditions
    • ·         Define amantadine and modafinil and the MOA of the agents
    • ·         Analyze the current pharmacotherapy used in awakening patient who have neurological deficits
    • ·         Compare amantadine and modafinil studies
    • ·         Provide recommendations for use of modafinil or amantadine based on presented evidence

    Objectives for Pharmacy Technicians      

    At the conclusion of this activity, pharmacy technicians should be able to:

    • 1.      Identify common neurological conditions in neurocritical care patients that may affect consciousness and responsiveness.
    • 2.      Describe the basic mechanisms of action and common uses of amantadine and modafinil in patients with neurological deficits.
    • 3.      Recognize key medication-safety considerations for amantadine and modafinil, including dosing, adverse effects, monitoring needs, and the pharmacy technician’s role in supporting safe medication use.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-056-L01-P; 0108-0000-26-056-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: 
    https://vshp.org/event-6885725
     


  • 10/29/2026 3:28 PM | Steve Glass (Administrator)

    VSHP Webinar 

    October 29, 2026 – 12:00pm-1:00 pm

    Acute Pulmonary Embolism: What’s New and What It Means for Practice

    Speaker:

    Jacqueline Ashby, PharmD

    PGY1 Resident Pharmacist

    Chippenham & Johnston-Willis Hospitals

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • Describe key updates and recommendations in the 2026 AHA/ACC guideline for the management of acute PE
    • Define criteria for acute PE categorization per 2026 AHA/ACC guideline
    • Identify an appropriate therapeutic strategy for PE based on patient-specific factors
    • Discuss a guideline-based plan for post-PE follow-up

    Objectives for Pharmacy Technicians      

    At the conclusion of this activity, pharmacy technicians should be able to:

    1. Identify key updates and recommendations in the 2026 AHA/ACC guideline for the management of acute pulmonary embolism (PE).
    2. Describe the criteria used to categorize acute PE according to the 2026 AHA/ACC guideline.
    3. Differentiate commonly used anticoagulant and thrombolytic therapies for acute PE based on general patient and medication-related factors.
    4. Explain the importance of medication access, adherence, monitoring, and follow-up after an acute PE.
    5. Describe the pharmacy technician’s role in supporting the safe preparation, dispensing, and distribution of medications used to manage acute PE.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-050-L01-P; 0108-0000-26-050-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register:  https://vshp.org/event-6867233

     


  • 08/20/2026 12:00 PM | Steve Glass (Administrator)

    VSHP Webinar 

    Thursday, August 20, 2026 – 12:00pm-1:00 pm

    HIV for the Inpatient Pharmacist

    Speaker:

    Kristen Lindauer, Pharm.D., BCPS, AAHIVP

    Clinical Pharmacy Specialist - Infectious Diseases/HIV

    Sentara Norfolk General Hospital

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • ·         Create a “pharmacist checklist” to optimize care for inpatients with HIV
    • ·         Discuss the prevalence of medication errors in people with HIV (PWH)
    • ·         Recognize key drug adjustments and interactions to manage care for PWH
    • ·         Identify FDA-approved two-drug regimens and injectable antiretrovirals

    Objectives for Pharmacy Technicians      

    At the conclusion of this activity, pharmacy technicians should be able to:

    1. Identify key components of a pharmacy checklist used to support safe medication management for hospitalized patients with HIV.
    2. Describe common medication errors involving antiretroviral therapy in people with HIV.
    3. Recognize antiretroviral medications that may require dosage adjustments or screening for significant drug interactions.
    4. Identify FDA-approved two-drug HIV regimens and injectable antiretroviral therapies.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-047-L02-P; 0108-0000-26-047-L02-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_tER64-ljSei4zzOuOsMNtg


  • 06/25/2026 12:00 PM | Steve Glass (Administrator)

    VSHP Webinar 

    Recording Available

    Thursday, June 25, 2026 – 12:00pm-1:00 pm

    Lipid-ly Evolving: What’s New for the 2026 Dyslipidemia Guidelines

     

    Speaker:

     

    Amanda Murray, PharmD
    PGY2 Ambulatory Care Resident 

    VCU School of Pharmacy 

     

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • 1) Discuss new updates for cardiovascular risk assessment from the 2026 ACC/AHA Multisocietal Guidelines on the Management of Dyslipidemia 
    • 2) Summarize the pharmacological treatment algorithms and goals for therapy for primary and secondary prevention
    • 3) Apply 2026 guideline-directed recommendations to a patient case Recognize how the characteristics of different anticoagulants affect their use peri-operatively

     

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    Describe key updates in cardiovascular risk assessment from the 2026 ACC/AHA Multisocietal Guidelines on the Management of Dyslipidemia.

    Summarize pharmacologic treatment approaches and therapeutic goals used for primary and secondary prevention of cardiovascular disease.

     Identify patient and treatment factors that influence guideline-directed dyslipidemia management and cardiovascular risk reduction strategies.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-045-L01-P; 0108-0000-26-045-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_UlhnS477RTePvmKFOqtO0Q 


  • 06/18/2026 12:00 PM | Steve Glass (Administrator)

    VSHP Webinar 

    Recording Available

    Thursday, June 18, 2026 – 12:00pm-1:00 pm

    Management of Psychotropic Medication Adverse Events

     

    Speaker:

     

    Jennifer Jacobson, PharmD

    PGY1 Pharmacy Resident 

    Chesapeake Regional Medical Center (CRMC)

    Chesapeake, VA

     

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • Discuss the epidemiology, clinical presentation, risk factors, and mechanisms of psychotropic medication-related adverse events.
    • Analyze current literature about prevention and management of psychotropic medication-related adverse events.
    • Identify appropriate pharmacologic and nonpharmacologic treatments for psychotropic medication-related adverse events.

     

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    Recognize common adverse events associated with psychotropic medications and identify patient factors that may increase the risk of these medication-related complications.

    Describe strategies used to prevent and manage psychotropic medication-related adverse events, including the role of medication monitoring, patient education, and interdisciplinary communication.

    Identify pharmacologic and nonpharmacologic approaches used to address psychotropic medication-related adverse events and understand the pharmacy technician's role in supporting safe medication use.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-046-L01-P; 0108-0000-26-046-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_xgm9z26wQLCNsIu72h6VWQ

     


  • 05/05/2026 11:27 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Recording Available

    Thursday, May 28, 2026 – 12:00pm-1:00 pm

    To Hold or Not to Hold: Updates in Periprocedural Anticoagulation

     

    Speaker:

     

    Trevor Shaffer, PharmD

    PGY1 Pharmacy Practice Resident 

    Winchester Medical Center

     

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • Recognize how the characteristics of different anticoagulants affect their use peri-operatively
    • Identify which procedures require adjustments to anticoagulation
    • Determine the timing for when different anticoagulants should be discontinued or re-initiated
    • Apply knowledge learned to a given patient case scenario

     

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    Identify common anticoagulants (e.g., warfarin, DOACs, heparins) and their key characteristics that influence

    peri-operative management (e.g., half-life, route, monitoring needs).

    Recognize types of surgical and procedural scenarios that may require adjustments to anticoagulation therapy.

    Describe general timing considerations for holding and restarting different anticoagulants based on procedure

    risk and medication characteristics.

    Explain factors that impact peri-operative anticoagulation decisions, including bleeding risk, renal function, and

    indication for therapy.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-044-L01-P; 0108-0000-26-044-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_T8YCKyjfQzu1WG0XrhURmg


  • 04/27/2026 5:28 PM | Steve Glass (Administrator)

    VSHP Webinar 

    Recording Available

    Tuesday, May 26, 2026 – 3:00pm-4:00 pm

    When BiTE Therapy Bites Back: Toxicities of Bispecific Antibody Therapies

    Speaker:

    Morgan Chatterley PharmD

    PGY1 Pharmacy Practice Resident 

    CJW Medical Center

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • ·         Describe the pathophysiology and risk factors associated with bispecific therapy (BiTE) toxicities including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
    • ·         Identify clinical signs, symptoms, and grading criteria used to recognize these toxicities.
    • ·         Compare current guideline-recommended pharmacologic and supportive management strategies for CRS, and ICANS.
    • ·         Review prophylactic strategies to prevent CRS with specific BiTE therapies.

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    1. Describe the pathophysiology and risk factors associated with bispecific therapy (BiTE) toxicities including

    cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).

    2. List clinical signs, symptoms, and grading criteria used to recognize these toxicities.

    3. Recite prophylactic strategies to prevent CRS with specific BiTE therapies.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-034-L01-P; 0108-0000-26-034-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_gV_r1oMeRea79t1goTzgPw


  • 04/14/2026 11:43 AM | Steve Glass (Administrator)

    VSHP Webinar 

    Recording Available

    Thursday, May 7, 2026 – 12:00pm-1:00 pm

    A Review of Cystic Fibrosis Modulator Therapies 

     

    Speaker:

     

    Kirstin Wade, PharmD, MBA

    PGY1 Pharmacy Resident 

    Winchester Medical Center 

     

    Objectives for Pharmacists

    At the completion of this activity, the participant will be able to:

    • Recognize how cystic fibrosis is diagnosed 
    • Describe the pathophysiology of cystic fibrosis 
    • Evaluate how different CFTR modulators work 
    • Apply knowledge of CFTR modulator therapies to a patient case 

     

    Objectives for Pharmacy Technicians      

    At the completion of this activity, the participant will be able to:

    • ·         Describecommon methods used to diagnose cystic fibrosis, including newborn screening, sweat chloride testing, and genetic testing.
    • ·         Explainthe basic pathophysiology of cystic fibrosis, including how CFTR gene mutations affect mucus production and organ function.
    • ·         Identifydifferent CFTR modulator therapies and summarize their general mechanisms of action (e.g., potentiators vs. correctors).
    • ·         Recognizekey differences among available CFTR modulators, including combination therapies and their general indications.

    Accreditation:

    Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.  Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit. 

    ACPE UAN:  0108-0000-26-043-L01-P; 0108-0000-26-043-L01-T

    Activity type: Application-based

    This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

    Non-members will be charged $20.

    To register: https://us06web.zoom.us/webinar/register/WN_3hUlVotISs6XAKxrdzIu3g


<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Contacts

contact@vshp.org

tel:  850-728-4474

fax:  678-401-0259

Copyright© 2026, Virginia Society of Health-System Pharmacists. All rights reserved.                                                                                                 

Powered by Wild Apricot Membership Software